---
schema_version: "secwatch.filing_event.v1"
accession: "0001562762-23-000295"
form_type: "8-K"
ticker: null
cik: "0001851657"
company_name: "Vaxxinity, Inc."
filed_at: "2023-07-27T23:59:59+00:00"
generated_at: "2026-06-13T00:55:36.412087+00:00"
event_type: "other_material"
sentiment: "negative"
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# Vaxxinity auditor Armanino resigns; appoints Peter Powchik as EVP Global Scientific Director

## Summary
- Armanino LLP resigns as auditor effective upon new appointment or Q3 2023 filing; cites transition away from public company audits.
- No disagreements or reportable events in past two fiscal years and subsequent interim period.
- Company warns inability to timely replace auditor could impair SEC filings, capital raising, and investor confidence.
- Peter Powchik, M.D. appointed EVP, Global Scientific Director effective Oct 1, 2023; previously led development of seven approved drugs at Regeneron.
- Ulo Palm transitions from CMO to senior advisor effective Oct 1, 2023; oversaw Phase 3 COVID-19 and Phase 1 Parkinson's trials.

## SEC filing metadata
- accession: 0001562762-23-000295
- form_type: 8-K
- cik: 0001851657
- company_name: Vaxxinity, Inc.
- filed_at: 2023-07-27T23:59:59+00:00
- event_type: other_material
- sentiment: negative
- materiality_score: 0.65
- calibrated_materiality_score: 0.65
- confidence: high
- sec_items: 4.01, 5.02, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1851657/000156276223000295/0001562762-23-000295-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1851657/000156276223000295/20230726_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001562762-23-000295
- JSON: https://secwatch.observer/filing/0001562762-23-000295.json
- Plain text: https://secwatch.observer/filing/0001562762-23-000295.txt

## Key facts
- Auditor Changes
  Armanino LLP resigned as auditor of Vaxxinity, Inc..
  - Action: resignation
  - Auditor: Armanino LLP
  source text: (the “Company”) was informed by Armanino LLP (“Armanino”) that it intends to resign as the Company’s independent registered public accounting firm, effective upon the earlier of (i) filing of the Company’s Quarterly Report on Form 10-Q for the quarter ending September 30, 2023 and (ii) the Company’s appointment of a new independent registered public accounting firm. The audit committee of the Company’s board of directors accepted but did not request or recommend Armanino’s resignation. Armanino advised the Company that its decision was due to Armanino’s transition away from providing financial statement audit services to public companies.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1851657/000156276223000295/0001562762-23-000295-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.